Third-line treatment patterns and clinical outcomes for metastatic colorectal cancer: a retrospective real-world study.

ABSTRACT:

Background

There are multiple recommendations on the third-line therapy of metastatic colorectal cancer (mCRC); however, no consensus has been reached.

Objectives

This study aimed to explore the patient demographics and the real-world third-line treatment landscape of mCRC.

Design

A retrospective real-world cohort study.

Methods

Electronic medical records of mCRC patients from Tianjin Medical University Cancer Institute and Hospital between 2013 and 2020 were collected. Upon descriptive, comparative, and survival analyses, a retrospective study was conducted to describe demographics and clinical outcomes of mCRC patients receiving third-line treatment.

Results

Among 218 mCRC patients receiving third-line therapy, 65.5% received chemotherapy combined with

SUBMITTER: Deng T 

PROVIDER: S-EPMC10501067 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature